CLADRIBINE Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description 2'-Deoxyadenosine in which the hydrogen at position 2 on the purine ring has been substituted by chlorine. It inhibits the synthesis and repair of DNA, particularly in lymphocytes and monocytes, and is used as an antimetabolite antineoplastic drug for the treatment of lymphoid malignancies including hairy-cell leukaemia and chronic lymphocytic leukaemia. (Chemical Entities of Biological Interest Ontology, CHEBI_567361)
External Link https://dgidb.org/results?searchType=drug&searchTerms=CLADRIBINE
Similar Terms
Downloads & Tools

Genes

15 interacting proteins for the CLADRIBINE drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
NT5C1A 5'-nucleotidase, cytosolic IA 2.35253
BCL2L2 BCL2-like 2 1.17627
DCK deoxycytidine kinase 0.9624
DIABLO diablo, IAP-binding mitochondrial protein 0.6416
RRM2B ribonucleotide reductase M2 B (TP53 inducible) 0.542892
RRM2 ribonucleotide reductase M2 0.470507
RRM1 ribonucleotide reductase M1 0.35288
XIAP X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase 0.294067
CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1) 0.235253
ADA adenosine deaminase 0.147033
IL2RA interleukin 2 receptor, alpha 0.133162
TGFB1 transforming growth factor, beta 1 0.11962
YES1 YES proto-oncogene 1, Src family tyrosine kinase 0.0165671
TP53 tumor protein p53 0.0076713
NFE2L2 nuclear factor, erythroid 2-like 2 0.00419596